Researchers showed that an experimental therapy indirectly converted suppressive immune cells into tumor-fighting cells. This ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Kazia Therapeutics Limited , a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment resistance, announces the in-licensing of a first-in-class ...
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced positive data from its HT-VA study, conducted under its Cooperative Research and Development ...
It is a privilege to lead a charity dedicated entirely to wildlife protection and restoration, as Yorkshire Wildlife Trust ...
Lockheed Martin Corp. (NYSE:LMT) has secured two contract modifications from the U.S. Department of War totaling $91,867,982.
The Print on MSN
Cancer therapy may soon skip the lab step — and cut costs
Early data suggests single-infusion treatment can safely reprogram immune cells inside the body, opening doors to more ...
Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective ...
Board of Alders New Haven Notice] The Joint Community Development/Health & Human Services Committee will meet in person on Wednesday, April 15, 2026, at 6:00 P.M, in the Board of Alders Chamber, 165 ...
India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has received clearance from the U.S. Food and Drug Administration (FDA)-the ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
Super-enhancers (SEs) are large clusters of transcriptional regulatory elements that drive oncogene expression, maintain malignancy, and create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results